The ketogenic diet restricts carbohydrates to <50g/day (typically 5% of calories) to deplete glycogen stores and shift primary fuel metabolism to fatty acid oxidation and hepatic ketone body production (beta-hydroxybutyrate, acetoacetate) — which the brain and other tissues use as alternative fuel. Originally developed for epilepsy treatment (with remarkable efficacy), it has demonstrated benefits for insulin resistance reversal, neurological conditions, certain cancers, and as a weight loss approach, alongside potential risks including kidney stone formation, dyslipidemia (particularly elevated LDL in some individuals), and the micronutrient and fiber inadequacy of poorly planned implementations.
Role
The ketogenic diet occupies the most contested space in contemporary nutrition — with legitimate clinical applications, a robust mechanistic rationale, and genuine efficacy for specific conditions existing alongside commercial exploitation, inappropriate universalization, and a concerning lack of long-term safety data beyond 2 years. The critical nuance most missing from public ketogenic diet discourse is the distinction between a therapeutic, medically supervised ketogenic diet and the commercially promoted low-carbohydrate approach that may or may not achieve ketosis, may or may not be nutritionally adequate, and is being applied to population segments for whom the risk-benefit calculation has never been properly established.